ALMS - Alumis Inc.
24.02
-0.730 -3.039%
Share volume: 1,107,379
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$24.75
-0.73
-0.03%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-13-2024 | 11-13-2024 | 03-19-2025 | 05-14-2025 | 11-13-2025 | 03-19-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 17.389 M | 2.066 M | 1.929 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 17.389 M | 2.066 M | 1.929 M | |
| nan% | nan% | -88.12% | -6.63% | ||||
| Operating expenses | 56.140 M | 98.399 M | 0.000 | 118.917 M | 117.358 M | 98.374 M | |
| Selling general and admin | 7.575 M | 10.575 M | 0.000 | 22.295 M | 19.522 M | 15.589 M | |
| Research and development | 48.565 M | 87.824 M | 0.000 | 96.622 M | 97.836 M | 82.785 M | |
| Total expenses | 56.140 M | 98.399 M | 0.000 | 118.917 M | 117.358 M | 98.374 M | |
| 75.27% | -100.00% | -1.31% | -16.18% | ||||
| Operating income | -56.140 M | -98.399 M | 0.000 | -101.528 M | -115.292 M | -96.445 M | |
| Ebit | -58.485 M | -98.439 M | 0.000 | -101.572 M | -115.346 M | -96.478 M | |
| Pretax income | -56.508 M | -93.117 M | 0.000 | -98.963 M | -110.752 M | -92.931 M | |
| 64.79% | -100.00% | 11.91% | -16.09% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -56.508 M | -93.117 M | 0.000 | -98.963 M | -110.752 M | -92.931 M | |
| -64.79% | 100.00% | -11.91% | 16.09% |